HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Viola Vaccarino Selected Research

5'-N-methylcarboxamideadenosine

1/2021Association Between Early Trauma and Ideal Cardiovascular Health Among Black Americans: Results From the Morehouse-Emory Cardiovascular (MECA) Center for Health Equity.
1/2020Cardiovascular Risk and Resilience Among Black Adults: Rationale and Design of the MECA Study.
1/2019Identification of Resilient and At-Risk Neighborhoods for Cardiovascular Disease Among Black Residents: the Morehouse-Emory Cardiovascular (MECA) Center for Health Equity Study.
1/2019Individual Characteristics of Resilience are Associated With Lower-Than-Expected Neighborhood Rates of Cardiovascular Disease in Blacks: Results From the Morehouse-Emory Cardiovascular (MECA) Center for Health Equity Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Viola Vaccarino Research Topics

Disease

27Myocardial Infarction
11/2021 - 11/2002
22Inflammation (Inflammations)
12/2021 - 02/2002
22Coronary Artery Disease (Coronary Atherosclerosis)
11/2021 - 03/2004
19Cardiovascular Diseases (Cardiovascular Disease)
04/2021 - 01/2008
17Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
02/2022 - 07/2009
14Hypertension (High Blood Pressure)
01/2020 - 11/2007
13Atherosclerosis
01/2019 - 03/2004
9Heart Failure
11/2020 - 09/2002
9Coronary Disease (Coronary Heart Disease)
11/2016 - 01/2004
8Myocardial Ischemia (Ischemic Heart Diseases)
12/2020 - 09/2014
8Ischemia
01/2020 - 11/2007
6Wounds and Injuries (Trauma)
11/2021 - 02/2012
6Metabolic Syndrome (Dysmetabolic Syndrome X)
10/2021 - 01/2008
6Diabetes Mellitus
01/2018 - 11/2002
6Obesity
05/2014 - 02/2002
5Atrial Fibrillation
01/2020 - 11/2013
5Stroke (Strokes)
11/2016 - 11/2007
5Glucose Intolerance
01/2010 - 06/2006
4Unstable Angina
11/2021 - 01/2020
3Type 2 Diabetes Mellitus (MODY)
10/2021 - 04/2009
3Mental Disorders (Mental Disorder)
09/2020 - 06/2013
3Chest Pain (Chest Pains)
12/2019 - 02/2012
3Acquired Immunodeficiency Syndrome (AIDS)
05/2016 - 03/2010
3Chronic Renal Insufficiency
09/2014 - 10/2006
2Pathologic Constriction (Stenosis)
11/2021 - 03/2004
2COVID-19
06/2021 - 04/2020
2Major Depressive Disorder (Major Depressive Disorders)
04/2021 - 09/2008
2Psychological Trauma
11/2020 - 01/2020
2Hyperlipidemias (Hyperlipidemia)
01/2020 - 01/2018
2Cognitive Dysfunction
01/2020 - 01/2019
2Ischemic Stroke
01/2019 - 11/2016
2Menstruation Disturbances
01/2016 - 04/2008
2Insulin Resistance
09/2014 - 11/2011
2Medically Unexplained Symptoms
01/2012 - 07/2009
2Prediabetic State (Prediabetes)
06/2010 - 09/2008
2Asthma (Bronchial Asthma)
03/2009 - 11/2007
1Hyperglycemia
10/2021
1Genetic Risk Score
01/2021

Drug/Important Bio-Agent (IBA)

20Biomarkers (Surrogate Marker)IBA
12/2021 - 03/2006
19C-Reactive ProteinIBA
11/2021 - 02/2002
13Interleukin-6 (Interleukin 6)IBA
12/2021 - 09/2008
8salicylhydroxamic acid (SHAM)IBA
01/2022 - 01/2020
8Glucose (Dextrose)FDA LinkGeneric
09/2017 - 06/2006
7LipidsIBA
01/2021 - 09/2002
6Troponin IIBA
12/2020 - 01/2018
5omega-Chloroacetophenone (Mace)IBA
12/2020 - 06/2008
4Biological ProductsIBA
02/2022 - 09/2014
45'-N-methylcarboxamideadenosineIBA
01/2021 - 01/2019
4cytidylyl-(3'-5')-cytidine (CpC)IBA
01/2020 - 01/2018
4TroponinIBA
01/2020 - 01/2018
4Hormones (Hormone)IBA
01/2020 - 03/2004
4CholesterolIBA
01/2020 - 02/2002
4Indicators and Reagents (Reagents)IBA
01/2019 - 02/2007
4Glutathione (Reduced Glutathione)IBA
01/2016 - 03/2006
4Fibrinogen (Factor I)FDA Link
05/2013 - 06/2002
4HDL CholesterolIBA
04/2010 - 10/2008
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2020 - 09/2008
3InterleukinsIBA
12/2020 - 11/2007
3Urokinase Plasminogen Activator ReceptorsIBA
01/2020 - 09/2017
3Vitamin DFDA LinkGeneric
09/2014 - 01/2014
3Glutathione Disulfide (GSSG)FDA LinkGeneric
04/2011 - 03/2006
3Triglycerides (Triacylglycerol)IBA
04/2010 - 04/2009
3CreatinineIBA
07/2008 - 02/2003
2Antidepressive Agents (Antidepressants)IBA
01/2022 - 01/2019
2Proteins (Proteins, Gene)FDA Link
10/2021 - 01/2006
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2020 - 08/2005
2CXC ChemokinesIBA
02/2018 - 01/2018
2Technetium Tc 99m Sestamibi (Cardiolite)FDA LinkGeneric
02/2018 - 01/2018
2Cystine (L-Cystine)IBA
01/2018 - 01/2016
2Testosterone (Sustanon)FDA Link
10/2017 - 01/2016
2FlavonoidsIBA
11/2016 - 11/2016
2AmmoniaIBA
09/2014 - 09/2013
2ORALIT (ORS)IBA
07/2014 - 02/2012
2AdiponectinIBA
01/2014 - 11/2011
2Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
05/2013 - 03/2011
2leukotriene A4 hydrolaseIBA
01/2013 - 01/2006
2EnzymesIBA
01/2013 - 09/2008
2LDL CholesterolIBA
04/2010 - 01/2009
2Hydrocortisone (Cortisol)FDA LinkGeneric
08/2009 - 07/2009
2HDL LipoproteinsIBA
04/2009 - 10/2008
2Phosphorus (Red Phosphorus)IBA
01/2009 - 08/2008
1PlacebosIBA
12/2021
1Acetylcholine (Acetylcholine Chloride)FDA Link
11/2021
1ThioredoxinsIBA
10/2021
1P-SelectinIBA
10/2021
1Particulate MatterIBA
10/2021
1Matrix Metalloproteinases (MMPs)IBA
10/2021
1insulin receptor-related receptor (IRR)IBA
06/2021
1HomocysteineIBA
04/2021
1Interferon-gamma (Interferon, gamma)IBA
12/2020

Therapy/Procedure

10Vagus Nerve Stimulation
01/2022 - 01/2019
6Therapeutics
11/2021 - 03/2004
5Coronary Artery Bypass (Coronary Artery Bypass Surgery)
04/2017 - 02/2004
3Percutaneous Coronary Intervention
12/2019 - 02/2004
3Mediterranean Diet
01/2018 - 01/2008
3Medication Reconciliation
05/2016 - 03/2010
2Patient Readmission
01/2017 - 07/2009
2Secondary Prevention
08/2013 - 10/2008
2Cardiac Rehabilitation
09/2012 - 01/2004
2Stents
04/2009 - 02/2004